RAYMOND PLODKOWSKI: Open Payments
NPI 1104831247 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$119,031 in 160 payments from 7 companies in 2025. Trend: 2023 $68,434 · 2024 $113,166 · 2025 $119,031
Speaker / faculty: $109,225Travel & lodging: $6,878Food & beverage: $2,928
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 78 | $61,039 |
| Novo Nordisk Inc | 56 | $48,409 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 18 | $9,395 |
| Madrigal Pharmaceuticals | 3 | $89 |
| Currax Pharmaceuticals LLC | 3 | $47 |
| Ascendis Pharma Endocrinology Inc | 1 | $29 |
| Sequel Med Tech, LLC | 1 | $24 |
Products named: ZEPBOUND, Wegovy, JARDIANCE, REZDIFFRA, MOUNJARO, CONTRAVE, Yorvipath, TWIIST.
Industry payments across CA — which companies pay providers there.
